M2 Presswire - Biovail Corp and Wellbutrin In Review.
Wednesday, November 26th, 2008M2 PRESSWIRE-17 January 2007-Pinnacle Digest: Biovail Corp and Wellbutrin In Review(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:17012007 Biovail Corporation (NYSE:BVF) (TSX:BVF) experienced a gain of 2.29 Tuesday accompanied by 421,066 shares trading hands. Their marketing partner GlaxoSmithKline is on the move and recently announced that that Wellbutrin XR(R)(1) (bupropion hydrochloride modified-re…
